Clinicopathologic parameter | No. of patients | Patients with 18F-FDG–avid tumor | Odds ratio | P |
Tumor site | ||||
Proximal third | 7 | 5 (71%) | 1.62 [0.27–9.85] | 0.64 |
Distal two thirds | 28 | 17 (61%) | 1 | |
Whole/diffuse | 5 | 4 (80%) | 2.59 [0.25–26.31] | |
Tumor size | ||||
Small (<3 cm) | 8 | 2 (25%) | 1 | 0.009* |
Large (>3 cm) | 32 | 24 (75%) | 9 [1.5–53.86] | |
WHO classification | ||||
SRC | 15 | 5 (33%) | 1 | 0.001* |
Non-SRC | 25 | 21 (84%) | 10.5 [2.31–47.77] | |
Lauren classification | ||||
Diffuse | 22 | 11 (50%) | 1 | 0.03* |
Intestinal | 17 | 14 (82%) | 4.67 [1.04–20.94] | |
Missing | 1 | 1 | 1 | |
Mucinous content | ||||
Mucinous | 6 | 5 (83%) | 3.1 [0.32–29.53] | 0.28 |
Nonmucinous | 34 | 21 (62%) | 1 | |
Stage | ||||
EGC | 6 | 2 (33%) | 1 | 0.09 |
AGC | 34 | 24 (71%) | 4.8 [0.75–30.55] | |
GLUT1 status | ||||
Positive | 18 | 16 (89%) | 11 [1.95–62] | 0.002* |
Negative | 19 | 8 (42%) | 1 | |
Missing | 3 | 2 | 1 |
↵* Statistically significant.
For 1 patient, Lauren classification was not known; for 3 patients, GLUT1 results were unavailable. Data in brackets are 95% confidence interval.